China again announces slashing of import duties on drugs from India

China agrees to slash import duty on Cancer drugs from India. Chinese authorities have announced of slashing import duties on drugs from India twice in as many months. Removing import duty on drugs from India is to reduce bilateral trade deficit or to mitigate need of medicines in China. Answers Punit Rasadia Recently, Spokesperson of … Continue reading China again announces slashing of import duties on drugs from India

Anlon Healthcare: working hard for healthier tomorrow

Anlon Healthcare: working hard for healthier tomorrow To harness the strength of technology and research into becoming a leading global pharmaceutical company that delivers maximum consumer satisfaction. Innovation is seen what everybody has seen and thinking of what nobody has thought. Change is called for an innovation and innovation leads to progress. With this very … Continue reading Anlon Healthcare: working hard for healthier tomorrow

Anlon launches gel based Torrid Plus for instant pain relief

Ahmedabad (Gujarat, India), Wednesday, July 4, 2018: Keeping the football fever on during the ongoing FIFA World Cup, Rajkot based pharmaceuticals startup, Anlon Lifescience has launched over-the-counter “Torrid - Plus” for instant pain relief here on today.  The gel based instant pain reliever works like a wonder on joints pain, sprains and strains, muscular pain, … Continue reading Anlon launches gel based Torrid Plus for instant pain relief

Indian drug manufacturers can take advantage of shutdown of Chinese pharma companies

There is a huge demand of APIs and Intermediates in China and Indian manufacturers should be in a position to fulfill the demand-supply gap created in the Chinese market writes Punit Rasadia According to a research report titled "The Effect of Environmental Regulation on Employment in Resource-Based Areas of China—An Empirical Research Based on the … Continue reading Indian drug manufacturers can take advantage of shutdown of Chinese pharma companies

Anlon participates at the BIO KOREA 2018 International Convention

Anlon, Pharmaceuticals, Bio Korea, APIs, Intermediate

Rajkot based pharmaceuticals startup, Anlon, a research-intensive organization which is into manufacturing of APIs and intermediates, process control instruments and pharmaceutical products has announced that it has presented at the BIO KOREA 2018 International Convention held on and from May 9-11, 2018, at COEX in Seoul in South Korea. Anlon has already earned a global … Continue reading Anlon participates at the BIO KOREA 2018 International Convention

China exempting import duty on 28 drugs may boost India’s pharma sector

China exempting import duty on 28 drugs may boost India’s pharma sector By Punit Rasadia Recently, China has announced the lifting of import duties on as many as 28 medicines, including all cancer drugs from 1 May. This move would definitely help India to export these pharmaceuticals to the neighbouring country. China has exempted import … Continue reading China exempting import duty on 28 drugs may boost India’s pharma sector

The state-of-the-art R&D facility creates a distinctive advantage for Anlon Group

ANLON Group is a research-intensive organization is into manufacturing of APIs and intermediates, process control instruments and pharmaceutical products. Based in Rajkot in Gujarat in India, ANLON Group has already earned a global recognition for manufacturing products that adhere to the highest standards of quality. ANLON Group has three major divisions - Anlon Healthcare Private … Continue reading The state-of-the-art R&D facility creates a distinctive advantage for Anlon Group